ABSTRACT LAU, H. S. (University of Kentucky, Lexington), AND R. F. WISEMAN. Effect of uric acid on riboflavine production by intestinal coliform bacteria. J. Bacteriol. 87:337-340. 1964.-Cultures of Escherichia coli, Aerobacter aerogenes, and Paracolobactrum species, isolated from human feces and from intestinal contents of rats, were tested for riboflavine synthesis in a chemically defined medium. Riboflavine was assayed by a fluorometric method and by microbiological assay. When uric acid was added to the synthetic medium at levels ranging from 10 to 750 ,g/ml, it inhibited the production of riboflavine, but did not affect the growth of the bacteria. As the amount of uric acid in the medium was increased from 10 to 750 ,g, there was a corresponding decrease in the amount of riboflavine produced. Some disappearance of uric acid was observed in the cultures. These results suggest that uric acid, or its degradation products, may have acted as an antimetabolite or an enzyme inactivator in the biosynthesis of riboflavine. De and Roy (1950) reported that the quantity of urinary and fecal riboflavine was decreased in rats fed riboflavine-deficient diets containing uric acid. They suggested that this decrease was probably due to the inhibition of the growth of riboflavine-synthesizing intestinal bacteria by uric acid, but did not present data supporting this view. Our study reports the in vitro effect of uric acid upon growth and riboflavine-synthesizing ability of intestinal coliform bacteria.
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MATERIALS AND METHODS
Coliform bacteria were isolated from human feces and from rat intestinal contents on Chapman's (1947) Tergitol-7 agar, and were identified by the method of Wiseman and Sarles (1956) .
The isolates were grown in the complete synthetic medium of Waring and Werkman (1943) and in synthetic media containing 10, 25, 50, 100, 250, 500, and 750 ,g/ml, of uric acid. The pH of each medium was maintained at 7.0 i 0.2. The media were distributed in 100-ml volumes into 250-ml "red" Erlenmeyer flasks (Pyrex, low actinic). The flasks were plugged and autoclaved at 121 C for 10 min. Stock uric acid solution was prepared according to the method of Varley (1960) .
Standard inocula were prepared from bacteria grown in nutrient broth and subcultured on 3 successive days at 37 C. The cultures were centrifuged and washed three times with sterile physiological saline. Standard suspensions were prepared by using a no. 3 McFarland nephelometer standard; 0.5-ml amounts of these suspensions were used as inocula.
Growth was measured by plate counts; 0.1-ml amounts of the dilutions of 48-hr cultures were surface inoculated onto Chapman's (1947) agar. Triplicate plates were made of each dilution and were incubated at 37 C for 24 hr.
Riboflavine was assayed by the technique of Kodicek and Wang (1949) and by the microbiological method of Snell (1950) . To each culture was added 1 ml of 10 % HCl to assure an acid pH. The acidified cultures were autoclaved for 10 min at 121 C to liberate bound riboflavine.
After cooling, the cultures were filtered through Whatman no. 40 paper, and the clear filtrates were used for riboflavine assay. Fluorescence was determined in a Coleman model 12 C electronicphotofluorometer.
The amount of uric acid remaining in the cultures after 48 hr of incubation at 37 C was determined by the method of Bare and Wiseman (1963) . Filtrates of the cultures were prepared as for riboflavine assay. Prior to determination of the uric acid levels, the filtrates were adjusted to pH 8 to 9 with 10 N NaOH with a Beckman model H2 pH meter.
RESULTS
From 80 isolates were selected 27 cultures of coliform bacteria, 9 isolated from human feces, and 9 each from the contents of the small intestines and of the ceca of rats ( Effect of uric acid on riboflavine production.
51, 53, and 61
The effect of uric acid on the production of riboflavine by the coliform isolates is presented 52 and 54
in Fig. 1 through 3 . The human E. coli ( Fig. 1 coli and Aerobacter aerogenes were isolated from both the human and the rat sources. Paracolobactrum species were isolated only from the rats.
Ejiect of uric acid on growth of coliform bacteria. Growth of the isolates in the synthetic medium, as determined by plate counts, was similar regardless of the amount of uric acid in the medium. The results of the plate counts of E. coli are presented in Fig. 1 . The counts of human E. coli ranged from 5.5 X 1011 to 8.0 x 1011 cells per ml of culture, whereas those of the rat isolates ranged from 1.2 X 1010 to 3.6 X 1010 cells per ml. The counts of A. aerogenes from both the human and rat. sources (Fig. 2) 
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by these E. coli isolates ranged from 0.075 to 0.084 ,ug/ml. This represents an average decrease of 38.4% of the riboflavine produced in the absence of uric acid.
The E. coli isolates from the rat intestinal contents produced from 0.055 to 0.069 ,g/ml of riboflavine in the synthetic medium without uric acid. In concentrations of uric acid from 10 to 750 ,ug/ml, the inhibitory effect increased up to the 500 ,ug/ml concentration, and decreased slightly at 750 Ag/ml. At the concentration of 500 Aug/ml of uric acid, the amount of riboflavine ranged from 0.031 to 0.040 ,g/ml, an average decrease of 39.7% of the amount produced in the absence of uric acid.
There was no apparent difference in the amount of riboflavine synthesized by the isolates from human and rat sources of A. aerogenes (Fig. 2) . In the absence of uric acid, the Aerobacter isolates produced from 0.098 to 0.122 ,ug of riboflavine per ml of bacterial filtrate. In concentrations of uric acid of from 10 to 750 ,ug/ml, there was a proportionate inhibition of riboflavine synthesis. At the concentration of 750 ,ug/ml, the amount of riboflavine produced varied from 0.036 to 0.076 ,ug/ml, an average decrease of 51.2% from that produced in the absence of uric acid.
Paracolobactrum isolates (Fig. 3) produced from 0.080 to 0.088 ,ug/ml of riboflavine in the absence of uric acid. In the presence of 750 ,g/ml of uric acid, the amount of riboflavine produced varied from 0.051 to 0.062 ,ug/ml, an average decrease of 33.2%.
Determination of uiric acid in culture filtrates. Determination was made of the uric acid levels in the filtrates of the cultures of five isolates after incubation at 37 C for 48 hr. Regardless of the initial level of uric acid in the medium, there was a decrease in the quantity of uric acid in all the cultures (Table 2 ).
DIscussIoN
Our results reveal that uric acid at levels of 10 to 750 ,g/ml inhibits the in vitro production of riboflavine by intestinal coliform bacteria, but does not interfere with the growth of the bacteria. This finding may explain in part that of I)e and Roy (1950) that the quantity of urinary and fecal riboflavine decreases in rats fed riboflavine-deficient diets containing uric acid.
However, that this decrease could have been due to the inhibition of the growth of riboflavine- That uric acid affects the biosynthesis of riboflavine, and not the growth of the organisms, suggests that these two metabolic processes may be physiologically independent. Mickelson (1950) noted that, at the end of 24 hr, over 85% of the glucose in the culture medium was fermented by Ashbya gossypii, but only a trace of riboflavine could be detected at this time. Riboflavine was readily detectable in the medium after 48 hr, and reached a peak at the end of the seventh day. Kapralek (1962) observed that three phases of metabolic activity occurred during the submerged batch cultivation of a riboflavine-producing strain of Eremothecium ashbyii. The "phase of growth" was characterized by mycelial synthesis. After growth ceased, the culture entered the "phase of production" in which riboflavine was produced. The "phase of autolysis" was characterized by release of riboflavine into the medium.
These observations indicate that growth and riboflavine synthesis may be separate yet continuous processes in the metabolism of these microorganisms. The phase of riboflavine production begins when the phase of growth "ends."
It appears that a similar system operates in the production of riboflavine by intestinal coliforms.
There (M\Iac-Laren, 1952; Gini and Krishnaswamy, 1954; Brown, 1960) . Because uric acid is structurally related to these purines, it is reasonable to assume that uric acid may have acted as an antimetabolite in )reventing the l)urine from participating in the synthesis of riboflav-in1e.
Although riboflavine-producing coliforms are capable of degrading uric acid (Mitchell and Levine, 1938; Thornsberry and Wliseman, 1960; Armstrong and WNiseman, 1962) , there is a lack of information concerning the specific effect of the degradation products of uric acid on riboflavine biosynthesis. The only evidence that a degradation product of uric acid may be inhibitory to riboflavine biosynthesis was presented by Burkholder (1943) , who noted that urea at a concentration of 0.2 to 0.4%O inhibited flavinogenesis by yeast.
(ii) Uric acid may have exerted its action by inactivating an enzyme system which is involved in the biosynthesis of riboflavine. Hargreaves et al. (1959) reported that uric acid inhibited catalase activity in vitro. Because catalase is physiologically coupled with flavoprotein enzymes, the decrease of catalase activity may result in the decrease of riboflav-ine production.
